课题基金 / 基金详情

California Clinical and Translational Pain Research Consortium

California Clinical and Translational Pain Research Consortium
加州临床和转化疼痛研究联盟
批准号:
10888865
负责人:
MARK S WALLACE
金额:
$10.26万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-30 至 2024-08-31

项目摘要

项目成果

MARK S WALLACE的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 加州大学临床和跨部门疼痛研究中心��um(CCTPRC)是 2019年获得NIH U24(NS115714)拨款。预算在U24被削减时被削减了 获奖。这要求我们减少ff�鳄鱼、PM和研究协调员的工作量。 尽管我们能够通过组合冗余来简化effi效率和成本 在CCTPRC的其他NIH Hear拨款之间,高于预期的屏幕/屏幕 EN20-01和EN21-01研究的失败使预算捉襟见肘,资金耗尽 2024年3月。我们正在申请Adi�的国家资金,以帮助我们度过5年的预算时期。 我们将把这笔资金用于这两项研究的其他招聘方式。� BioInformation a�cs以在电子病历中搜索符合fi条件的受试者。将使用两种方法,批处理 电子邮件和陌生电话。我们将监视Screen to Randomiza�on ra�o的成功并恢复到 该方法产生了最高的随机性�on。这也将使我们能够重新fiNed招聘 Eff为未来的EPPIC-Net研究做准备。
英文摘要
Abstract The University of California Clinical and Transla�onal Pain Research Consor�um (CCTPRC) was awarded the NIH U24 (NS115714) grant in 2019. The budget was reduced when the U24 was awarded. This required us to reduce effort for the Inves�gators, PM and study coordinator. Although we were able to streamline the efficiency and costs by combining redundancy between other NIH HEAL grants across the CCTPRC, the higher-than-expected screen/screen failure ra�o for the EN20-01 and EN21-01 studies strained the budget with funds running out March 2024. We are asking for addi�onal funds to get us through the 5-year budget period. We will use the funds toward other recruitment methods for the two studies u�lizing bioinforma�cs to search the EHR for qualified subjects. Two methods will be used, batch emailing and cold calls. We will monitor success of screen to randomiza�on ra�o and revert to the method yielding the highest randomiza�ons. This will also allow us to refined recruitment efforts for future EPPIC-Net studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFICACY OF INHALED CANNABIS FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
EFFICACY OF INHALED CANNABIS FOR THE TREATMENT OF PAINFUL DIABETIC NEUROPATHY
EFFECTS OF SPINAL CORD STIMULATION ON EXPERIMENTALLY INDUCED WIND-UP
ANALGESIC EFFICACY OF SMOKED CANNABIS IN REFRACTORY CANCER PAIN
海外基金